• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

贝叶斯半参数荟萃分析-预测先验在临床试验中对历史对照数据的借鉴。

Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.

机构信息

Takeda Pharmaceuticals, Cambridge, Massachusetts, USA.

出版信息

Stat Med. 2021 Jun 30;40(14):3385-3399. doi: 10.1002/sim.8970. Epub 2021 Apr 13.

DOI:10.1002/sim.8970
PMID:33851441
Abstract

When designing a clinical trial, borrowing historical control information can provide a more efficient approach by reducing the necessary control arm sample size while still yielding increased power. Several Bayesian methods for incorporating historical information via a prior distribution have been proposed, for example, (modified) power prior, (robust) meta-analytic predictive prior. When utilizing historical control borrowing, the prior parameter(s) must be specified to determine the magnitude of borrowing before the current data are observed. Thus, a flexible prior is needed in case of heterogeneity between historic trials or prior data conflict with the current trial. To incorporate the ability to selectively borrow historic information, we propose a Bayesian semiparametric meta-analytic-predictive prior. Using a Dirichlet process mixture prior allows for relaxation of parametric assumptions, and lets the model adaptively learn the relationship between the historic and current control data. Additionally, we generalize a method for estimating the prior effective sample size (ESS) for the proposed prior. This gives an intuitive quantification of the amount of information borrowed from historical trials, and aids in tuning the prior to the specific task at hand. We illustrate the effectiveness of the proposed methodology by comparing performance between existing methods in an extensive simulation study and a phase II proof-of-concept trial in ankylosing spondylitis. In summary, our proposed robustification of the meta-analytic-predictive prior alleviates the need for prespecifying the amount of borrowing, providing a more flexible and robust method to integrate historical data from multiple study sources in the design and analysis of clinical trials.

摘要

在设计临床试验时,通过借用历史对照信息,可以通过减少对照臂所需的样本量来提供更有效的方法,同时提高功效。已经提出了几种通过先验分布将历史信息纳入的贝叶斯方法,例如(修正的)功效先验、(稳健的)荟萃分析预测先验。在利用历史对照借用时,必须指定先验参数,以在观察当前数据之前确定借用的程度。因此,如果历史试验之间存在异质性,或者先验数据与当前试验相冲突,就需要灵活的先验。为了纳入有选择性地借用历史信息的能力,我们提出了一种贝叶斯半参数荟萃分析预测先验。使用狄利克雷过程混合先验可以放宽参数假设,并使模型自适应地学习历史和当前对照数据之间的关系。此外,我们推广了一种用于估计所提出先验的先验有效样本量(ESS)的方法。这可以直观地量化从历史试验中借用的信息量,并有助于根据特定任务调整先验。我们通过在广泛的模拟研究和强直性脊柱炎的 II 期概念验证试验中比较现有方法之间的性能,来说明所提出方法的有效性。总之,我们对荟萃分析预测先验的稳健性改进缓解了预先指定借用程度的需求,为在临床试验的设计和分析中整合来自多个研究来源的历史数据提供了更灵活和稳健的方法。

相似文献

1
Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.贝叶斯半参数荟萃分析-预测先验在临床试验中对历史对照数据的借鉴。
Stat Med. 2021 Jun 30;40(14):3385-3399. doi: 10.1002/sim.8970. Epub 2021 Apr 13.
2
Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical data.基于倾向评分的元分析预测先验,用于纳入真实世界和历史数据。
Stat Med. 2021 Sep 30;40(22):4794-4808. doi: 10.1002/sim.9095. Epub 2021 Jun 14.
3
A novel power prior approach for borrowing historical control data in clinical trials.一种在临床试验中借用历史对照数据的新型功率先验方法。
Stat Methods Med Res. 2023 Mar;32(3):493-508. doi: 10.1177/09622802221146309. Epub 2023 Jan 4.
4
BEATS: Bayesian hybrid design with flexible sample size adaptation for time-to-event endpoints.BEATS:用于生存时间终点的具有灵活样本量调整的贝叶斯混合设计。
Stat Med. 2023 Dec 30;42(30):5708-5722. doi: 10.1002/sim.9936. Epub 2023 Oct 19.
5
Robust meta-analytic-predictive priors in clinical trials with historical control information.具有历史对照信息的临床试验中的稳健元分析预测先验。
Biometrics. 2014 Dec;70(4):1023-32. doi: 10.1111/biom.12242. Epub 2014 Oct 29.
6
Bayesian borrowing from historical control data in a vaccine efficacy trial.疫苗效力试验中借鉴历史对照数据的贝叶斯方法
Pharm Stat. 2023 Sep-Oct;22(5):815-835. doi: 10.1002/pst.2313. Epub 2023 May 24.
7
Borrowing historical information to improve phase I clinical trials using meta-analytic-predictive priors.借鉴历史信息,利用荟萃分析预测先验来改进I期临床试验。
J Biopharm Stat. 2022 Jan 2;32(1):34-52. doi: 10.1080/10543406.2022.2058526. Epub 2022 May 20.
8
Elastic meta-analytic-predictive prior for dynamically borrowing information from historical data with application to biosimilar clinical trials.弹性元分析预测先验,用于从历史数据中动态借用信息,应用于生物类似药临床试验。
Contemp Clin Trials. 2021 Nov;110:106559. doi: 10.1016/j.cct.2021.106559. Epub 2021 Sep 17.
9
Sample size calculation for clinical trials analyzed with the meta-analytic-predictive approach.临床试验样本量计算的荟萃分析预测方法分析。
Res Synth Methods. 2023 May;14(3):396-413. doi: 10.1002/jrsm.1618. Epub 2023 Jan 14.
10
Comparative Study of Bayesian Information Borrowing Methods in Oncology Clinical Trials.贝叶斯信息借用方法在肿瘤临床试验中的比较研究。
JCO Precis Oncol. 2022 Mar;6:e2100394. doi: 10.1200/PO.21.00394.

引用本文的文献

1
Matching-Assisted Power Prior for Incorporating Real-World Data in Randomized Clinical Trial Analysis.用于在随机临床试验分析中纳入真实世界数据的匹配辅助功率先验法。
Stat Med. 2025 Feb 10;44(3-4):e10342. doi: 10.1002/sim.10342.
2
Use of external control arms in immune-mediated inflammatory diseases: a systematic review.使用外部控制臂治疗免疫介导的炎症性疾病:系统评价。
BMJ Open. 2023 Dec 9;13(12):e076677. doi: 10.1136/bmjopen-2023-076677.
3
On the use of non-concurrent controls in platform trials: a scoping review.在平台试验中使用非同期对照:范围综述。
Trials. 2023 Jun 15;24(1):408. doi: 10.1186/s13063-023-07398-7.
4
An Improved Matching Practice for Augmenting a Randomized Clinical Trial with External Control.一种用于通过外部对照增强随机临床试验的改进匹配方法。
Ther Innov Regul Sci. 2023 May;57(3):611-618. doi: 10.1007/s43441-023-00497-2. Epub 2023 Feb 21.
5
Machine Learning and Artificial Intelligence in Pharmaceutical Research and Development: a Review.机器学习和人工智能在药物研发中的应用:综述。
AAPS J. 2022 Jan 4;24(1):19. doi: 10.1208/s12248-021-00644-3.